Paul is dying on Coronation Street.
Peter Ash has spoken about the incredible response he's experienced following the portrayal of Paul Foreman's motor neurone disease diagnosis.
On Coronation Street, Paul has been slowly deteriorating after being diagnosed with the degenerative disease, which currently has no cure.
The performance has been widely praised by critics and fans alike, with it also picking up the award for Best Storyline at the RadioTimes.com Soap Awards, sponsored by Inspired Villages.
Ash spoke to us ahead of winning the award and opened up on the public response to the important storyline.
"With a storyline like that there's a lot of pressure to get it right," Ash said. "Obviously you don't want to misrepresent it or anything, so there is a lot of research being done.
"It's tough and it's been such a heavy storyline, but it feels good knowing we're getting it right."
Ash continued: "The response to it has been amazing from people living with MND themselves, and also their families responding to it, so it's been amazing in that regard."
Taking on the storyline, of course, means that Paul will die, and Ash will have to leave the soap, something the actor has "mixed emotions" about.
"It's a bit of a double-edged sword. Really sad to go, but really grateful that they trusted me with this storyline."
Ash's on-screen partner, Daniel Brocklebank, also paid tribute to the storyline and Ash's performance at the RadioTimes.com Soap Awards.
Read more:
The RadioTimes.com Soap Awards 2024, sponsored by Inspired Villages, took place on 13th July. Find out more about the winners!
Check out more of our Soaps coverage or visit our TV Guide and Streaming Guide to find out what else is on. For more from the biggest stars in TV, listen to The Radio Times Podcast.
Helen Daly is the Associate Editor for Radio Times, overseeing new initiatives and commercial projects for the brand. She was previously Deputy TV Editor at a national publication. She has a BA in English Literature and an MA in Media & Journalism from Newcastle University.
Find out the pros and cons of equity release and request a free guide.
By entering your details, you are agreeing to our terms and conditions and privacy policy. You can unsubscribe at any time.